Dr. Bekaii-Saab earned his medical degree from the American University of Beirut in Lebanon. This was followed by a residency in internal medicine at Indiana University Medical Center in Indianapolis, Indiana. He then completed fellowships in clinical pharmacology and experimental therapeutics and hematology/oncology at Tufts University/New England Medical Center in Boston, Massachusetts. Dr. Bekaii-Saab joined the faculty at the Mayo Clinic in May 2016 as Co-Leader of the Enterprise wide Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center and Professor at the Mayo Clinic College of Medicine and Science. He is also a Senior Associate Consultant, Division of Hematology and Oncology in Mayo Clinic Arizona.
He was previously at the Ohio State University – Arthur G. James Cancer Hospital and Solove Research Institute as a tenured Professor of Medicine and Pharmacy, and Section Chief for the Gastrointestinal Cancer Program. Dr. Bekaii-Saab is actively involved in the American Society of Clinical Oncology, American Association for Cancer Research and the American Society for Clinical Pharmacology and Therapeutics. Additionally, he is the co-leader for the hepato-biliary cancer committee for the Alliance cooperative group, and is the Alliance representative for the NCI hepato-biliary national cancer task force.
Dr. Bekaii-Saab is also the senior executive leader for solid tumor research and GI cancer committee co-lead for the Mayo clinic sponsored ACCRU network which includes more than 110 institutions and practices from all over the US, Canada and Singapore. Dr. Bekaii-Saab has additionally served as a reviewer for more than 50 of the most prestigious journals.